Olympiad Research’s Incyte INCY Stock Holding History

Olympiad Research’s Portfolio INCY Stock Details INCY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-3,017	Closed	-$298K	–	115
2025 Q4	$298K	Sell	3,017 -2,181	-42%	-$211K	0.79%	31
2025 Q3	$441K	Buy	5,198 +1,064	+26%	+$84.1K	0.61%	23
2025 Q2	$282K	Buy	+4,134	New	+$262K	0.46%	59

Other funds holding INCY

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Olympiad Research's INCY Position: Q1 2026 in Review

Olympiad Research sold out of Incyte (INCY) in Q1 2026, closing a stake of 3,017 shares — an estimated $298K sold.

Olympiad Research first reported a position in INCY in Q2 2025 and held it in 3 quarters. The position peaked at $441K in Q3 2025. 815 funds tracked by Wall St. Rank hold INCY as of Q1 2026.

Olympiad Research reported no remaining Incyte position as of Q1 2026 after selling out during the quarter.
Olympiad Research sold 3,017 Incyte shares in Q1 2026, an estimated $298K.
Olympiad Research first reported a position in Incyte in Q2 2025 and held it in 3 quarters.
Olympiad Research's Incyte position peaked at $441K in Q3 2025.
815 funds tracked by Wall St. Rank held Incyte as of Q1 2026.

Based on Olympiad Research's 13F filing for Q1 2026, filed 13 May 2026.